Vivos Therapeutics, Inc. Number of Reportable Segments
Vivos Therapeutics, Inc. (VVOS) reported Number of Reportable Segments of 1 Integer for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-04-15
- Vivos Therapeutics, Inc. number of reportable segments for fiscal 2025 was 1.00 Integer, a 0.00% change from fiscal 2024.
- Vivos Therapeutics, Inc. number of reportable segments for fiscal 2024 was 1.00 Integer.
Integer
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2025-12-31 | 1.00 Integer 10-K · filed 2026-04-15 |
| 2024-12-31 | 1.00 Integer 10-K · filed 2025-03-31 |
Segment
| Period end | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month |
|---|---|---|
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-19 | |
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |